Mylan Laboratories to Acquire Up to 71.5% Controlling Interest in Matrix Laboratories (PR Newswire via Yahoo! Finance)
Mylan Laboratories Inc. and Matrix Laboratories Ltd. today announced that Mylan will acquire up to 71.5% of Matrix shares outstanding for Rs. 306 per Matrix share.

New vaccine prevents cervical cancer but also raises sexuality issues (Daily Bulletin)
Most parents willingly roll up their children's sleeves for shots to ward off everything from mumps and chickenpox to tetanus and hepatitis.

FDA expected to back expanded use of Plan B contraceptive (Boston Globe)
WASHINGTON -- The Food and Drug Administration will approve an application, possibly today, that would make the emergency contraceptive Plan B available without a prescription to women 18 and older, say sources long involved with the issue.